Hepato(Geno)toxicity Assessment of Different Bromelain Food Supplements in HepG2 Cell Line Model by the Comet Assay


DOI:
https://doi.org/10.62482/pmj.19Keywords:
Bromelain food supplement, hepato(geno)toxicity, comet assay, MTTAbstract
Introduction: Food supplements have become increasingly popular to support nutrition, improve overall health, and prevent diseases, yet their safety and efficacy remain under scrutiny due to limited regulation and inconsistent quality standards. Bromelain, a proteolytic enzyme mixture derived from pineapples, has gained attention due to its traditional medicinal uses and anti-inflammatory, antiedematous, and antithrombotic effects. This study aimed to evaluate the hepato(geno)toxicity potential of bromelain food supplement samples on human liver cell lines, purchased from a pharmacy and an online retailer. In view of the increasing usage of bromelain, its promising pharmacological activities, and the limited toxicological data, the research highlights the potential risks associated with unregulated and widely accessible bromelain products, particularly those purchased online.
Methods: A colorimetric MTT (3-dimethylthiazol-2,5-diphenyltetrazolium bromide) assay was conducted to determine the IC50 concentrations, while the genotoxic potential of bromelain food supplement samples on human liver cell lines, were evaluated using the alkaline single-cell gel electrophoresis assay (Comet Assay).
Results: No statistically significant differences in genotoxic potential were observed for either product in the HepG2 cell line when compared to the solvent control and the negative control at both tested concentrations (IC25 and IC50).
Conclusion: Although no risks were identified for the tested products, the safety and authenticity of food supplements purchased online remain uncertain. Addressing regulatory and safety gaps requires harmonized vigilance systems, stricter marketing regulations, and increased public awareness to ensure their safe use.
References
Ministry of Food, Agriculture and Livestock. Turkish Food Codex Regulation on Supplementary Foods (Regulation No: 2013/49). Official Gazette. 2013 Aug 16;28737:63. Available from: https://www.resmigazete.gov.tr/eskiler/2013/08/20130816.pdf
Ertaş M. Besin takviyelerinin bilinçli tüketiminin önemi. İstanbul Sabahattin Zaim Üniversitesi Fen Bilimleri Enstitüsü Dergisi. 2022;4(1):48-53. https://doi.org/10.47769/izufbed.1083778
Kanak E, Öztürk SN, Özdemir Y, Asan K, Öztürk Yılmaz S. Gıda takviyeleri kullanım alışkanlıklarının değerlendirilmesi. Niğde Ömer Halisdemir Üniversitesi Mühendislik Bilimleri Dergisi. 2021;10(1):168-177. https://doi.org/10.28948/ngumuh.783613
Harnack LJ, Rydell SA, Stang J. Prevalence of use of herbal products by adults in the Minneapolis/St Paul, Minn, metropolitan area. Mayo Clin Proc. 2001;76(7):688-94. https://doi.org/10.4065/76.7.688
Özdoğan M. Supplementlerin güvenliği konusunda ciddi eksiklikler var – örnekler ve çözüm önerileri. Prof. Dr. Mustafa Özdoğan [Internet]. [cited 2024 Dec 21]. Available from: https://www.drozdogan.com/supplement-vitamin-takviyeleri-zararlari-riskleri/
Varilla C, Marcone M, Paiva L, Baptista J. Bromelain, a group of pineapple proteolytic complex enzymes (Ananas comosus) and their possible therapeutic and clinical effects: a summary. Foods. 2021;10(10):2249. https://doi.org/10.3390/foods10102249
Maurer HR. Bromelain: biochemistry, pharmacology and medical use. Cell Mol Life Sci. 2001;58(9):1234-1245. https://doi.org/10.1007/PL00000936
Colletti A, Li S, Marengo M, Adinolfi S, Cravotto G. Recent advances and insights into bromelain processing, pharmacokinetics and therapeutic uses. Appl Sci. 2021;11(16):8428. https://doi.org/10.3390/app11188428
Hikisz P, Bernasinska-Slomczewska J. Beneficial properties of bromelain. Nutrients. 2021;13(12):4313. https://doi.org/10.3390/nu13124313
Ramli ANM, Aznan TNT, Illias RM. Bromelain: from production to commercialisation. J Sci Food Agric. 2016;96(13):5227-5235. https://doi.org/10.1002/jsfa.8122
Singh NP, McCoy MT, Tice RR, Schneider EL. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res. 1988;175(1):184-91. https://doi.org/10.1016/0014-4827(88)90265-0
Collins AR, Azqueta Oscoz A, Brunborg G, Gaivão I, Giovannelli L, Kruszewski M, Smith CC, Stetina R. The comet assay: topical issues. Mutagenesis. 2008;23(3):143-51. https://doi.org/10.1093/mutage/gem051
Taşkın T, Yesil Devecioglu T, Şenkardeş İ. Antioxidant, anti-urease activities and genotoxic effects of Terfezia claveryi methanol extracts on human lymphocytes. Clin Exp Health Sci. 2018;8(3):190-195. https://doi.org/10.5152/clinexphealthsci.2017.651
Abdel-Tawab M. Do we need plant food supplements? A critical examination of quality, safety, efficacy, and necessity for a new regulatory framework. Planta Med. 2018;84(6-07):372-393. https://doi.org/10.1055/s-0043-123764
Wróbel-Harmas M, Krysińska M, Postupolski J, Wysocki MJ. Food supplement-related risks in the light of internet and RASFF data. [Article in English, Polish]. Przegl Epidemiol. 2014;68(4):613-9. Available from: https://www.przeglepidemiol.pzh.gov.pl/Food-supplement-related-risks-in-the-light-oflntemet-and-RASFF-data,180443,0,2.html
Allkanjari O. The safety concern of plant-based supplements: a public health topic. Int J Health Plann Manage. 2021;36(4):1370-1372. https://doi.org/10.1002/hpm.3177
Vo Van Regnault G, Costa MC, Adanić Pajić A, Bico AP, Bischofova S, Blaznik U, Menniti-Ippolito F, Pilegaard K, Rodrigues C, Margaritis I. The need for European harmonization of nutrivigilance in a public health perspective: a comprehensive review. Crit Rev Food Sci Nutr. 2022;62(29):8230-8246. https://doi.org/10.1080/10408398.2021.1926904
Turkish Medicines and Medical Devices Agency (TMMDA). Good Pharmacovigilance Practices Guideline Module I: Management and Reporting of Adverse Drug Reactions. 2014 Apr 15. Available from: https://titck.gov.tr/duyuru/iyi-farmakovijilans-uygulamalari-ifu-kilavuzu-modul-i-ve-iyi-farmakovijilans-uygulamalari-kilavuzu-ek-i-yayimlanmistir-27122018172753
Agrawal P, Nikhade P, Patel A, Mankar N, Sedani S. Bromelain: a potent phytomedicine. Cureus. 2022;14(8):e27876. https://doi.org/10.7759/cureus.27876
Kumar V, Mangla B, Javed S, Ahsan W, Kumar P, Garga V, Dureja H. Bromelain: A review of its mechanisms, pharmacological effects and potential applications. Food Funct. 2023;14:8101. https://doi.org/10.1039/D3FO01060K
VigiAccess [Internet]. Uppsala (Sweden): Uppsala Monitoring Centre; [cited 2023 Dec 22]. Available from: https://www.vigiaccess.org.
Hamdy S. Bromelain monograph. Altern Med Rev. 2010;15(1):61-68. Available from: https://altmedrev.com/wp-content/uploads/2019/02/v15-4-361.pdf
Nettis E, Napoli G, Ferrannini A, Tursi A. IgE-mediated allergy to bromelain. Allergy. 2001;56(3):257-8. https://doi.org/10.1034/j.1398-9995.2001.056003257.x
Gailhofer G, Wilders-Truschnig M, Smolle J, Ludvan M. Asthma caused by bromelain: an occupational allergy. Clin Allergy. 1988;18(5):445-50. https://doi.org/10.1111/j.1365-2222.1988.tb02894.x
Elje E, Hesler M, Rundén-Pran E, Mann P, Mariussen E, Wagner S, Kohl Y. The comet assay applied to HepG2 liver spheroids. Mutat Res Genet Toxicol Environ Mutagen. 2019;845:403033. https://doi.org/10.1016/j.mrgentox.2019.03.006
Lee JH, Lee JT, Park HR, Kim JB. The potential use of bromelain as a natural oral medicine having anticarcinogenic activities. Food Sci Nutr. 2019;7(5):1656-1667. https://doi.org/10.1002/fsn3.999
Raeisi F, Raeisi E, Heidarian E, Shahbazi-Gahroui D, Lemoigne Y. Bromelain inhibitory effect on colony formation: an in vitro study on human AGS, PC3, and MCF7 cancer cells. J Med Signals Sens. 2019;9(4):267-273. https://doi.org/10.4103/jmss.jmss_42_18
Lee JS, Chu IS, Heo J, Calvisi DF, Sun Z, Roskams T, Durnez A, Demetris AJ, Thorgeirsson SS. Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling. Hepatology. 2004;40(3):667-76. https://10.1002/hep.20375
Murthy SS, Narsaiah TB. Cytotoxic effect of bromelain on HepG2 hepatocellular carcinoma cell line. Appl Biochem Biotechnol. 2021;193(6):1873-1897.https://doi.org/10.1007/s12010-021-03505-z
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Tugçe Yesil

This work is licensed under a Creative Commons Attribution 4.0 International License.